Bin-Yan Zhong

12PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRespiratory diseasesMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 16, 2026
TACE plus donafenib and immune checkpoint inhibitors for intermediate HCC (CHANCE2410 study): a propensity score matching analysis.

|Oct 28, 2024
Immune Indicator Changes in Hepatocellular Carcinoma Undergoing TACE Plus ICIs and Anti-VEGF Antibodies/TKIs: A Prognostic Biomarker Analysis.

Xiao-Yang Xu, Ze Wang, Chen-You Liu

|Aug 06, 2024
The Value of Neutrophil-to-Lymphocyte Ratio in Predicting Mortality After Transjugular Intrahepatic Portosystemic Shunt Placement.

Hao-Huan Tang, Lin-Feng Zhou, Chun-Xin Wang

|Feb 19, 2024
Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives.

Jian-Jian Chen, Zhi-Cheng Jin, Bin-Yan Zhong

|Nov 29, 2023
Prognosis Prediction of CRAFITY Score in HCC Undergoing TACE Combined with PD-(L)1 Inhibitors and Molecular Targeted Therapy.

Ze-Xin Hu, Xiao-Yang Xu, Ze Wang

|Oct 04, 2023
Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma with Child-Pugh B7.

Jian-Qiang Jiang, Jin-Tao Huang, Bin-Yan Zhong

Pageof 2

Frequent Collaborators

3 joint publications

Zhi-Cheng Jin

2 joint publications

Wei-Dong Wang

2 joint publications

Hai-Dong Zhu

1 joint publications

Xiao-Li Zhu